The CEO of pharmaceutical giant AstraZeneca warns that NHS patients may be limited to generic medicines unless the health service increases what it pays for branded drugs, raising concerns about access to cutting-edge treatments.
The UK government launches a national security probe into major pharmaceutical investments by US-based Pfizer and Denmark's Novo Nordisk, raising concerns about foreign influence in Britain's vital healthcare sector.
Investment professionals sound alarm as gold's spectacular rally shows signs of cracking. Discover why the precious metal's sudden decline could signal deeper market troubles ahead.
Exclusive: Health Secretary gains controversial new powers to fast-track medicines, raising concerns about inconsistent care across different regions of England.
Chancellor Rachel Reeves is actively seeking investment from Gulf nations including Saudi Arabia, raising questions about economic pragmatism versus ethical foreign policy in Labour's new government.
Exclusive investigation reveals dangerous counterfeit weight loss medications are being illegally sold across Britain, putting thousands at risk of serious health complications.
Exclusive analysis reveals how Lloyds Banking Group's patient investment strategy paid off spectacularly with their Ferrari stake, while Citigroup faces Hong Kong regulatory scrutiny in separate banking sector developments.
London's AIM market sees unprecedented gold investment surge as pandemic fears and economic instability drive investors toward traditional safe-haven assets. Expert analysis reveals shifting market trends.
Former President Donald Trump's proposed tariffs could dramatically increase costs for NHS medicines, potentially costing the health service billions and threatening patient care across the UK.
The NHS is rolling out three groundbreaking COVID-19 treatments to protect the most vulnerable, including molnupiravir and ritonavir, offering new hope for high-risk patients across the UK.
The UK's Alternative Investment Market (AIM) has delivered staggering returns that left the Dow Jones in the dust, with investment expert Russ Mould revealing which sectors drove this extraordinary performance.
Prominent British tech investor Eileen Burbidge warns that artificial intelligence stocks are showing worrying signs of a market bubble, drawing parallels to the dot-com era as valuations become dangerously detached from reality.
A groundbreaking HIV prevention injection offering six months of protection with lenacapavir will be available in 120 lower-income countries by 2027 through a landmark access agreement.
90s rap icon Vanilla Ice unveils his astonishing property success, transforming a £3.5k investment into a £4.5 million fortune through strategic renovations and market savvy. Discover his secrets.
Exclusive insight into how NHS England's shrewd negotiation tactics secure massive discounts on vital medicines, from cancer treatments to rare disease drugs, ensuring sustainable healthcare funding.
Former chief scientific adviser Sir Patrick Vallance warns that dwindling investment in medical research and innovation threatens the future of the NHS and patient care. Discover the urgent call for action.
Chancellor Rachel Reeves secures landmark £1 billion Google investment in UK AI infrastructure, marking a significant vote of confidence in Britain's tech economy during high-profile Trump meeting.
John Swinney claims Westminster is deliberately undermining Scottish economy by diverting a major foreign investment to Yorkshire, sparking a major constitutional row.
Sanofi executive warns of UK's worsening medicines access crisis, citing post-Brexit regulations, NICE hurdles, and a pricing system that deters investment and innovation.
Serena Williams' husband, Alexis Ohanian, headlines a landmark $1 billion investment consortium to revolutionise Chelsea FC Women, aiming to create a global football powerhouse and challenge US dominance.
Major international investors are abandoning Australia's offshore wind projects, dealing a devastating blow to the nation's clean energy transition and 2030 renewable targets. Discover the regulatory chaos and political uncertainty causing this crisis.
Exclusive investigation reveals how Oakland, California's plummeting house prices and strong dollar create a prime investment opportunity for British property hunters seeking value across the Atlantic.
Billionaire investor Warren Buffett admits to a colossal $11bn error in judgement with Kraft Heinz, calling it a 'bad investment' in a rare public mea culpa.
The World Health Organisation makes a landmark decision, adding weight-loss injections like Wegovy to its Essential Medicines List, signalling a new front in the global fight against obesity.
The Scottish Government is spearheading a massive £500 million investment in the Highlands and Islands' green energy sector, partnering with a US private equity firm to create sustainable jobs and boost the local economy.
Ireland's controversial €13 million sale of Israeli securities, prompted by human rights concerns, has ignited a political firestorm, drawn criticism from Israel, and raised questions over the strategic management of the €16 billion National Treasury Mana
Dubai's sovereign wealth fund secures a 10.3% stake in LSEG, marking a significant Middle Eastern investment in the heart of the UK's financial infrastructure and raising questions about foreign influence.
West Ham United's women's team is in exclusive negotiations with a US private equity firm for a significant strategic investment, signalling a major shift in the landscape of women's football ownership and finance.
Exclusive: Chelsea and England midfielder Cole Palmer makes a stunning off-pitch move, acquiring a prestigious French château and vineyard, trading the Premier League for Pinot in a remarkable investment.